Christian Beisland
Papers
5
Total Citations
53
H-Index
5
About
Christian Beisland is a leading urologic oncologist whose research has fundamentally advanced the surgical management of prostate and kidney cancers. His work centers on optimizing preoperative risk stratification and refining treatment protocols to improve patient outcomes. Beisland’s most impactful contribution is a 2017 study demonstrating how incorporating multiparametric MRI (mpMRI) features into established tools like CAPRA and D’Amico significantly enhances risk stratification for prostate cancer patients undergoing robot-assisted radical prostatectomy—a finding with 22 citations that has influenced clinical decision-making. He is also a driving force behind the Nordic Renal Cancer Group (NORENCA), which he co-founded in 2015 to harmonize kidney cancer treatment across Scandinavia. Through the RECUR European database, Beisland has characterized recurrence patterns in localized renal cell carcinoma, while his population-based analysis of Norwegian surgical practices for tumors ≤7 cm showed that adherence to evolving guidelines can improve overall survival. Additionally, his 2023 review on refractory bladder neck contracture after prostatectomy addresses a challenging complication with high patient burden. With over 50 publications and leadership in multi-national collaborations, Beisland continues to shape evidence-based urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5